No Data
Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)
Express News | "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
Truist Financial Gives a Hold Rating to Hims & Hers Health (HIMS)
Hims & Hers Health Insider Sold Shares Worth $2,653,129, According to a Recent SEC Filing
Josh Brown Unveils The 'Degen Dow,' A Basket Of 30 Retail Darlings Spanning All 'Major Degen Food Groups'
